David Badawi's most recent trade in Sight Sciences Inc was a trade of 21,270 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2026 | 21,270 | 0 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 19 Feb 2026 | 21,270 | 1,998,458 | - | 0.2 | 4,892 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 64,915 | 1,977,188 | - | 0 | Common Stock | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 16 Jan 2026 | 4,836 | 1,912,273 | - | 6.6 | 32,014 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 02 Jan 2026 | 3,695 | 1,917,109 | - | 7.5 | 27,639 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 02 Jan 2026 | 3,051 | 1,920,804 | - | 7.8 | 23,859 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 02 Jan 2026 | 2,914 | 1,923,855 | - | 7.4 | 21,651 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2025 | 21,270 | 21,270 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 26 Dec 2025 | 21,270 | 1,926,769 | - | 0.2 | 4,892 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 03 Oct 2025 | 6,033 | 1,864,992 | - | 3.3 | 19,728 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.12 per share. | 17 Jul 2025 | 40,000 | 1,871,025 | - | 0.1 | 4,800 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 03 Jul 2025 | 5,679 | 1,831,025 | - | 4.2 | 23,704 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 01 Apr 2025 | 5,980 | 1,836,704 | - | 2.3 | 13,772 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 98,566 | 1,842,684 | - | 0 | Common Stock | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 17 Jan 2025 | 5,423 | 1,744,118 | - | 2.8 | 15,081 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 08 Jan 2025 | 3,829 | 1,749,541 | - | 3.3 | 12,479 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.52 per share. | 03 Jan 2025 | 3,111 | 1,753,370 | - | 3.5 | 10,957 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.99 per share. | 02 Oct 2024 | 3,167 | 1,756,481 | - | 6.0 | 18,958 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.42 per share. | 01 Jul 2024 | 3,128 | 1,759,648 | - | 6.4 | 20,072 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 03 Apr 2024 | 3,128 | 1,762,776 | - | 5.1 | 15,887 | Common Stock |
| Sight Sciences Inc | Badawi David | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 108,645 | 1,765,904 | - | 0 | Common Stock | |
| Sight Sciences Inc | Badawi David | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.16 per share. | 17 Jan 2024 | 3,414 | 1,642,157 | - | 5.2 | 17,630 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.17 per share. | 03 Jan 2024 | 2,425 | 1,645,571 | - | 5.2 | 12,542 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 39,100 | 1,485,790 | - | 0 | Common Stock | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 28,100 | 1,488,221 | - | 0 | Common Stock | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 01 Jan 2023 | 2,431 | 1,485,790 | - | 12.2 | 29,683 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 21 Sep 2022 | 40,000 | 1,481,196 | - | 0.2 | 9,200 | Common Stock |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 40,000 | 42,540 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 112,400 | 112,400 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | David Badawi | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 28,100 | 28,100 | - | - | Restricted Stock Units |